Role of pretransplant anti-thymocyte globulin in matched sibling donor stem cell transplantation after reduced intensity conditioning for myelodysplastic syndrome.

Seung-Ah YahngGi-June MinSung Soo ParkSilvia ParkYoung-Woo JeonSung Soo ParkSeung-Hwan ShinSung-Eun LeeByung-Sik ChoKi-Seong EomSeok LeeChang-Ki MinHee-Je KimJong-Wook LeeYoo-Jin Kim

Published in: European journal of haematology (2020)

These findings suggest that ATG can be safely used to decrease moderate-to-severe chronic GVHD with improved GRFS for patients with MDS receiving MSD-HSCT in RIC setting.

Keyphrases

stem cell transplantation
high intensity
high dose
early onset
drug induced
hematopoietic stem cell
low dose